SURF – Surface Oncology Inc

Surface Oncology, Inc. 于2014年4月根据特拉华州法律注册成立,是一家临床阶段免疫肿瘤学公司,专注于利用其对免疫抑制肿瘤微环境至关重要的生物学途径或 TME 的专业知识,用于开发下一代癌症疗法。

中文介绍: https://xueqiu.com/S/SURF

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company’s pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.

英文介绍: https://www.morningstar.com/stocks/xnas/surf/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/surf-surface-oncology-inc/

发表评论

您的电子邮箱地址不会被公开。 必填项已用*标注